ZURICH (Reuters) - Swiss skincare firm Galderma on Thursday posted sales of $4.41 billion for 2024, up 9.3% from the same period a year earlier in constant currency terms.

Galderma's results come almost a year after the company listed on the Swiss stock exchange in March 2024, and its owners have gradually placed more and more shares on the market.

During that time, the value of the company's shares has more than doubled from its initial launch price.